Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00419965 · ClinicalTrials.gov registry record
Measuring G Protein-coupled Receptor Kinase-2 (GRK2) in the Blood to Diagnose and Treat Patients With Heart Failure
A clinical trial, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- 582
- Enrollment target
NCT00419965 is a clinical trial that has completed, run by Thomas Jefferson University. The registered enrollment target is 582 participants.
The verdict
NCT00419965 has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- 582 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine the utility of GRK2 to differentiate between normal patients and patient groups that differ by the presence/absence of HF symptoms, systolic or diastolic left ventricular dysfunction, and risk factors; and to evaluate if a new assay provides similar values as traditional methods for measuring GRK2 levels.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 582 participants |
| Start Date | 2006-10 |
| Est. Completion | 2010-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00419965
The ClinicalTrials.gov registry entry for NCT00419965 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 582 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00419965 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00419965 about?
NCT00419965 is a clinical study titled "Measuring G Protein-coupled Receptor Kinase-2 (GRK2) in the Blood to Diagnose and Treat Patients With Heart Failure". The primary objective of this study is to determine the utility of GRK2 to differentiate between normal patients and patient groups that differ by the presence/absence of HF symptoms, systolic or diastolic left ventricular dysfunction, and risk factors; and to evaluate if a new assay provides simila...
What is the current status of trial NCT00419965?
This trial is currently completed. The enrollment target is 582 participants. The study started on 2006-10. Estimated completion is 2010-05.
Who is sponsoring clinical trial NCT00419965?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.